Hasil Pencarian - Rijin Mohan
- Menampilkan 1 - 2 hasil dari 2
-
1
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India oleh Harbans Singh, Sumit Srivastava, Babita Yadav, Amit K. Rai, Sophia Jameela, Sanuj Muralidharan, Rijin Mohan, Shikha Chaudhary, Richa Singhal, Rakesh Rana, Shruti Khanduri, Bhagwan S. Sharma, Bhogavalli Chandrasekhararao, Narayanam Srikanth, Sarika Chaturvedi
Diterbitkan 2022-06-01
Artikel -
2
Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial oleh Harbans Singh, Babita Yadav, Amit K. Rai, Sumit Srivastava, AJV Saiprasad, Sophia Jameela, Richa Singhal, Sanuj Muralidharan, Rijin Mohan, Shikha Chaudhary, Rakesh Rana, Shruti Khanduri, Bhagwan S. Sharma, Bhogavalli Chandrasekhararao, Narayanam Srikanth, Kartar S. Dhiman
Diterbitkan 2023-09-01
Artikel